From Leapfrog to Kamikaze Science

Folks who limit their understanding to explanations from tv will not easily understand .

Pray for them. They’ll first have to read https://www.bucksafa11.org/of-humanized-mice-and-men/

where it is pointed out by science:

Antibody gene transfer is a novel protective strategy that bypasses the natural immune response, which has been the central focus of previous attempts to develop an HIV vaccine, by directing the production of antibodies from non-hematopoietic tissues, such as muscle (Figure 1). Because this approach skips many of the steps in the usual path of vaccine development, it has been described as a leapfrog strategy… 

before the Kamikaze reference is understood most will have to read this recent story…

https://www.the-scientist.com/news-opinion/renee-wegryzn-tapped-to-head-arpa-h-70478

where it is explained…

The new agency will support a broad range of programs aimed at preventing, detecting, and treating a variety of diseases, including cancer, according to the White House’s statement. However, rather than focusing on early research, STAT reports that ARPA-H will investigate higher-level solutions such as commercializing technology. Modeled on DARPA, the new agency is intended to speed the development of treatment and cures for diseases.

Earlier this year, ARPA-H received $1 billion in congressional funding to fulfill these objectives, and US Department of Health and Human Services (HHS) Secretary Xavier Becerra decided it would be part of the National Institutes of Health. As director of ARPA-H, Wegrzyn will report directly to Becerra…

Keep an eye on those VAERS numbers;  they may not remain believed as reliable by the CDC, thus requiring a new system of accountability with new scientific parameters.

Reflecting the change required in the  new order of things; survivors will catch on, I’m sure.

 

Leave a Reply

Your email address will not be published. Required fields are marked *